MedTech News
.................... by Andrew Celentano

FDA selects Dexcom for new digital health device pilot
The FDA announced today that it selected Dexcom (Nasdaq:DXCM) as the first manufacturer for a new digital health pilot.

Johnson & Johnson wins FDA nod for Ottava surgical robot
Johnson & Johnson (NYSE:JNJ) announced today that it received FDA de novo authorization for its Ottava surgical robot system.

High-speed 3D imaging reveals how seizures move through the brain
Seizures can race through the brain in seconds, making them difficult to capture in detail. To overcome this challenge, researchers have developed a new high-resolution light-sheet imaging system that is fast enough to image seizure propagation in the brain of a larval zebrafish in 3D.

Microneedles may help light reach hard-to-treat skin cancers
Photodynamic therapy (PDT) uses a light-sensitive drug and a specific wavelength of light to destroy cancer cells. The treatment has become an important option for certain skin cancers because it can target diseased tissue while limiting damage to surrounding skin. But PDT has a fundamental challenge: both the drug and the light must reach the same area of tissue.

What to know about the record-setting Cyclospora outbreak
Two Northwestern experts explain how to reduce risk without sacrificing a healthy diet

Philips gets FDA nod for next-gen reusable pulse oximetry clip sensor
Philips (NYSE:PHG) today announced that it received FDA 510(k) clearance for its next-generation reusable SpO₂ clip sensor.

Casana introduces smart toilet seat that measures blood pressure, heart rate
Casana announced today that it launched the Smart Seat, a smart toilet seat capable of measuring a range of metrics.

Tumor organoid tech advances precision medicine cancer treatments
Significant advances have been made in the development of patient-derived tumor “organoids” for preclinical research in two new studies led by Weill Cornell Medicine investigators. Organoids are three-dimensional clumps of cells that mimic structural and functional features of an organ, tumor or other tissue. The advances represent progress in precision medicine and point to the more routine use of tumor organoids as models for evaluating and optimizing cancer treatments.